0001628280-23-021962.txt : 20230613
0001628280-23-021962.hdr.sgml : 20230613
20230613164121
ACCESSION NUMBER: 0001628280-23-021962
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230609
FILED AS OF DATE: 20230613
DATE AS OF CHANGE: 20230613
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sullivan Christopher Ryan
CENTRAL INDEX KEY: 0001810417
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37590
FILM NUMBER: 231011749
MAIL ADDRESS:
STREET 1: C/O CERECOR INC.
STREET 2: 400 E. PRATT STREET, SUITE 606
CITY: BALTIMORE
STATE: MD
ZIP: 21202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Avalo Therapeutics, Inc.
CENTRAL INDEX KEY: 0001534120
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 450705648
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 540 GAITHER ROAD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 410-522-8707
MAIL ADDRESS:
STREET 1: 540 GAITHER ROAD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: Cerecor Inc.
DATE OF NAME CHANGE: 20111102
4
1
wk-form4_1686688870.xml
FORM 4
X0407
4
2023-06-09
0
0001534120
Avalo Therapeutics, Inc.
AVTX
0001810417
Sullivan Christopher Ryan
C/O AVALO THERAPEUTICS, INC.
540 GAITHER ROAD, SUITE 400
ROCKVILLE
MD
20850
0
1
0
0
Chief Financial Officer
0
Common Stock
2023-06-09
4
P
0
511
3.42
A
1262
D
These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan.
/s/ Jennifer Zoltoski, by Power of Attorney
2023-06-12